P00730 Recombinant Human BID/BH3-interacting domain death agonist 细胞因子/蛋白

P00730 Recombinant Human BID/B

H3-interacting domain death agonist 细胞因子/蛋白
收藏
  • ¥832 - 21120
  • Solarbio已认证
  • P00730
  • 北京
  • 2025年07月25日
    avatar
    品牌商
    13钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 库存

      现询

    • 供应商

      北京索莱宝科技有限公司

    • 规格

      1mg/500ug/50ug/10ug

    规格:1mg产品价格:¥21120.0
    规格:500ug产品价格:¥14784.0
    规格:50ug产品价格:¥2600.0
    规格:10ug产品价格:¥832.0
    基本信息
    基因名
    别名BH3-Interacting Domain Death Agonist;p22 BID;BID
    中文名称Recombinant Human BID/BH3-interacting domain death agonist
    外观(性状)Supplied as a 0.2 μm filtered solution of 20mM PB, 100mM KCl, pH 7.4.
    纯度≥95% as determined by reducing SDS-PAGE.
    储存条件Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.
    运输条件干冰运输
    背景说明BH3-Interacting Domain Death Agonist (BID) is a member of the Bcl-2 protein family which regulates outer mitochondrial membrane permeability.BID is a pro-apoptotic member that causes cytochrome c to be released from the mitochondria intermembrane space into the cytosol.Interaction of Bid with Bak causes altered mitochondrial membrane permeability.BID contains only the BH3 domain,which is required for its interaction with the Bcl-2 family proteins and for its pro-death activity.BID is susceptible to proteolytic cleavage by caspases,calpains,Granzyme B and cathepsins.It is an integrating key regulator of the intrinsic death pathway that amplifies caspase-dependent and caspase-independent execution of neuronal apoptosis.Therefore pharmacological inhibition of BID provides a promising therapeutic strategy in neurological diseases where programmed cell death is prominent,and also offer a new strategy for the treatment of acute renal failure associated with ischemia-reperfusion.BID receives direct inputs from a key regulator of the cell cycle arrest/DNA repair machinery (ATM),and therefore is an excellent candidate to coordinate genotoxic stress responses and apoptotic cell death.BID is a novel pro-apoptosis Bcl-2 family protein that is activated by caspase 8 in response to Fas/TNF-R1 death receptor signals.Deletion of BID inhibits carcinogenesis in the liver,although this genetic alteration promotes tumorigenesis in the myeloid cells.This is likely related to the function of BID to promote cell cycle progression into S phase.BID could be also involved in the maintenance of genomic stability by engaging at mitosis checkpoint.
    来源E.coli
    内毒素Less than 0.1 ng/ug(1 EU/ug)as determined by LAL test.
    单位

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    安元生物科技(南京)有限公司
    2025年07月14日询价
    ¥640
    上海羽哚生物科技有限公司
    2025年05月29日询价
    ¥1250
    上海优宁维生物科技股份有限公司
    2025年10月16日询价
    ¥4989
    上海嵘崴达实业有限公司
    2025年11月24日询价
    P00730 Recombinant Human BID/BH3-interacting domain death agonist 细胞因子/蛋白
    ¥832 - 21120